Category Specific RSS

par asx

Q&A: Paradigm to answer FDA questions to achieve Investigational New Drug status

The commercialisation of osteoarthritis treatment ZILOSULĀ® has hit a hiccup in the United States with the US Food and Drug…

4 years ago